Patents by Inventor Steven Wesolowski

Steven Wesolowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080269275
    Abstract: Compounds of Formula I wherein R1, D, R2, A and R3 are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
    Type: Application
    Filed: May 29, 2006
    Publication date: October 30, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Dean Brown, William Blackwell, Frances M. McLaren, Volker Schnecke, Reed W. Smith, Gary Steelman, Xia Wang, Rebecca Urbanek, Steven Wesolowski
  • Publication number: 20080064706
    Abstract: Compounds of formula: wherein Ar1 and Q are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the treatment of depression.
    Type: Application
    Filed: July 27, 2005
    Publication date: March 13, 2008
    Applicant: AstraZeneca AB
    Inventors: James Folmer, Simon Hunt, Peter Hamley, Steven Wesolowski
  • Publication number: 20070249618
    Abstract: Compounds of formula (I) wherein Ar1 and Q are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the treatment of depression.
    Type: Application
    Filed: July 27, 2005
    Publication date: October 25, 2007
    Applicant: AstraZeneca AB
    Inventors: James Folmer, Simon Hunt, Peter Hamley, Steven Wesolowski
  • Publication number: 20070191358
    Abstract: Compounds of formula: (chemical formula to be inserted here—please see paper copy) wherein Arl is as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the treatment of depression.
    Type: Application
    Filed: July 27, 2005
    Publication date: August 16, 2007
    Applicant: AstraZeneca AB
    Inventors: James Folmer, Simon Hunt, Peter Hamley, Steven Wesolowski